The Stimulus—What Does It Mean for Clinical Labs? by Greg ThompsonCrucial details are yet to come, but billions in health care dollars will likely affect clinical laboratories in ways both direct and indirect. Recovering with New Ta
Read MorePolymedco Inc announces the introduction of the PATHFAST immunoassay analyzer, manufactured by Mitsubishi Chemical Medience Corporation, Tokyo.
Read MoreA new article, Evaluation of Universal Antenatal Screening for Group B Streptococcus concludes that rapid, PCR-based testing at the time of admission for delivery may improve the accuracy of Group B streptococcal (GBS) screening over the normal antepartum testing done at 35-37 weeks of gestation.
Read MoreMarketResearch.com has announced the addition of Kalorama Information’s new report “Swine Influenza Market Alert (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays),” to their collection of Healthcare market reports.
Read MoreGenmica, a company of the Zeltia Group, is developing an updated version of its product CLART PneumoVir for the specific and urgent detection of the New A/H1N1 Influenza.
Read More